Health Strategies Group - Pharmaceutical and Biotech Articles

	Managed Markets
	Account Management Advantage NEW
	Best Practices
	Cross-Category Access NEW
	Pharmacy Benefit Managers
	Strategic Accounts

	Specialty Biotech
	Managed Care Complete NEW
	Oncology Performance Edge NEW
	Specialty Pharmacy Management
	Specialty Sales Opportunity Assessment

	Sales Representatives & Managers
	PharmaSME
	SFE Library
	Strategic Selling Outlook

	Institutional Markets
	HospitalSFE
	Institutional Provider Systems

	Government as Payer
	Managed Medicare Rx
	Medicaid Rx Payers

	Managed Markets Consulting


Oncology Performance Edge is a new market intelligence service from Health Strategies Group that puts oncology marketing and sales leaders on the right path to maximizing the performance of your oncology marketing and sales resources by: Providing an objective evaluation of the Oncology sales environment to help you anticipate future changes Describing and prioritizing customers’ needs: Oncologists, their staff and other influencers Comparing the performance of your sales team to relevant competitors so you can set priorities for POAs, coaching, training and other resource investments Sponsors will receive on-call access to our Oncology experts who can provide a broad perspective of business challenges and a view of best practices for addressing them. View our 2010 Oncology Performance Edge research schedule. View our 2011 Oncology Performance Edge research schedule.	Subscribing Companies Receive Five days of consulting time with our oncology experts Customized on-site briefings Opportunities for input into the research Reports in both print and electronic format Access to our website; customized for your organization Contact Oncology Performance Edge
Oncology Performance Edge Publications
2011 Optimizing Customer Support Beyond the Sales Representatives Coming March 2011 An assessment of successful relationships between oncology companies and their customers. Research will prioritize the activities that oncology companies need to provide beyond the sales representative to ensure success with their customers. Oncology Sales Opportunity Assessments Coming June 2011 An assessment of representative knowledge, behaviors, and resources that predict success in specific disease categories. Categories include breast, hematologic, GI/colorectal, lung, and prostate cancers. Total Office Call in the Oncology Market - 2011 Coming November 2011 This research analyzes the influencers in the oncology sales environment. The report identifies the important non-physician influencers and describes the most effective content, behaviors, knowledge, and resources for interacting with them. 2010 Oncology Sales Opportunity Assessments May 2010 An assessment of representative knowledge, behaviors and resources that predict success in a specific disease area. Breast Cancer Sales Opportunity Assessment May 2010 View Research Summary GI/Colorectal Cancer Sales Opportunity Assessment June 2010 View Research Summary Lung Cancer Sales Opportunity Assessment June 2010 View Research Summary Hematologic Cancer Sales Opportunity Assessment July 2010 View Research Summary Prostate Cancer Sales Opportunity Assessment Coming August 2010 Total Office Call in the Oncology Market 2010 July 6, 2010 An analysis of the influencers in the oncology sales environment. This research identifies the important ex-physician influencers and describes the most effective methods, tools, and messages for interacting with mid-level practitioners, nursing staff, reimbursement coordinators or office administrators, and infusion center personnel. View Research Summary Current and Future Selling Environment of the Oncology Market Coming December 2010 An overview of the key trends and dynamics affecting the selling environment for Oncology products. This analysis is focused on guiding selling strategies and resources for the next one to two years.